[Source: Nanchang Municipal Health Commission_Media reports] Recently, the interventional team of the third department of cardiovascular medicine at the Chaoyang Campus of Nanchang Third Hospital successfully performed the first TAVR (transcatheter aortic valve system implantatio

[Source: Nanchang Municipal Health Commission_Media Reports]

Recently, the interventional team of the Third Department of Cardiovascular Medicine at the Chaoyang Campus of Nanchang Third Hospital successfully performed the first TAVR (transcatheter aortic valve system implantation) surgery. This marks a new breakthrough in the diagnosis and treatment of heart valve disease in this hospital.

Two years ago, the patient Mr. Li (pseudonym) repeatedly experienced symptoms of chest tightness, shortness of breath, and dyspnea, which worsened in the past six months. He went to the hospital for treatment and was diagnosed with moderate to severe aortic valve stenosis with moderate regurgitation, and Patients with underlying diseases such as heart failure, coronary atherosclerosis, and cerebral infarction cannot tolerate surgical thoracotomy, and a comprehensive evaluation is appropriate for TAVR surgery. With the cooperation of multiple departments, the operation went smoothly. According to reports, TAVR surgery is an interventional treatment technology that does not require thoracotomy, has minimal trauma and fast postoperative recovery, and can bring hope to elderly patients with high surgical risks and patients with multiple organ diseases. In recent years, the medical team of the three cardiovascular departments of the hospital have refined their medical skills, continuously improved their medical technology, and provided better medical services to the public.

statement: The copyright of this article belongs to the original author. If there is an error in the source or infringement of your legitimate rights and interests, you can contact us via email and we will handle it in a timely manner. Email address: [email protected]